| Literature DB >> 33075855 |
Ji Hoon Bahk1, Young Hoon Kim1, Hyung Youl Park2, Hyung Ki Min1, Sang Il Kim1, Kee Yong Ha3.
Abstract
BACKGROUND: Spinal surgery holds a higher chance of unpredicted postoperative medical complications among orthopedic surgeries. Several studies have analyzed the risk factors for diverse postoperative medical complications, but the majority investigated incidences of each complication qualitatively. Among gastrointestinal complications, reports regarding postoperative ileus were relatively frequent. However, risk factors or incidences of hepatobiliary complications have yet to be investigated. The purpose of this study was to examine the incidence of gastrointestinal complications after spinal surgery, quantitatively analyze the risk factors of frequent complications, and to determine cues requiring early approaches.Entities:
Keywords: Digestive System Diseases; Incidence; Postoperative Complications; Risk Factors; Spinal Fusion
Mesh:
Substances:
Year: 2020 PMID: 33075855 PMCID: PMC7572230 DOI: 10.3346/jkms.2020.35.e345
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Group demographics of all 234 patients who underwent spinal fusion surgery
| Parameters | Values | |
|---|---|---|
| Average age, yr | 65.9 ± 13.0 | |
| Women, % | 62.5 | |
| Duration of anesthesia, min | 246.6 ± 83.2 | |
| ASA | 1.95 ± 0.4 | |
| No. of segments fused | 2.76 ± 1.89 | |
| Level of fusion | ||
| Limited to lumbar spine | 181 (77.4) | |
| Involves thoracolumbar junction | 34 (14.5) | |
| Limited to thoracic spine | 19 (8.12) | |
| Surgical approach | ||
| Posterolateral interbody fusion | 196 (83.8) | |
| Direct lateral interbody fusion | 22 (9.4) | |
| Combined fusion | 16 (6.8) | |
| Underlying diseases | ||
| Hypertension | 111 (47.0) | |
| Diabetes mellitus | 57 (24.4) | |
| Cancer | 36 (15.4) | |
| Endocrinology | 28 (12.0) | |
| Hepatobiliary | 25 (10.7) | |
| Rheumatology | 11 (4.7) | |
| Gastrointestinal | 8 (3.4) | |
| Charlson's comorbidity index | 2.86 ± 1.69 | |
Values are presented as mean ± standard deviation or number (%).
ASA = American Society of Anesthesiology.
Fig. 1Presented symptoms of gastrointestinal complications after spinal fusion. Abdominal pain (48%) was the predominant symptom perceived by the patients.
Fig. 2Diagnosed gastrointestinal and hepatobiliary complications of 31 (13.2%) cases after spinal fusion out of the total 234 patients. Paralytic ileus (52%) was observed most frequently. Indeed, the asymptomatic feature in the majority of cases of serum hepatobiliary marker elevations should be taken into account.
CHD = common hepatic duct.
Univariate logistic regression analysis for postoperative paralytic ileus after spinal fusion
| Items | OR | 95% CI | ||
|---|---|---|---|---|
| Age | 1.012 | 0.983–1.049 | 0.458 | |
| Gender, women:men | 1.432 | 0.645–3.428 | 0.394 | |
| Duration of anesthesia, hr | 1.373 | 1.001–1.010 | 0.015* | |
| ASA | 0.806 | 0.682–0.282 | 0.682 | |
| No. of fused segments | 1.202 | 0.047–0.996 | 0.047* | |
| Charlson's comorbidity index | 1.007 | 0.962–0.736 | 0.962 | |
| Underlying diseases | ||||
| Hypertension | 0.598 | 0.260–1.332 | 0.213 | |
| Diabetes mellitus | 0.278 | 0.064–0.831 | 0.042* | |
| Gastrointestinal | < 0.001 | N/A | 0.986 | |
| Hepatobiliary | 2.976 | 1.060–7.692 | 0.029* | |
| Endocrinology | 1.433 | 0.440–3.987 | 0.515 | |
| Rheumatology | 0.541 | 0.029–2.958 | 0.564 | |
| Cancer | 1.127 | 0.357–2.992 | 0.822 | |
| Surgical approach | ||||
| PLIF vs. DLIF | 1.510 | 0.403–4.599 | 0.497 | |
| PLIF vs. PLIF & DLIF | 2.427 | 0.635–7.695 | 0.153 | |
| DLIF vs. PLIF & DLIF | 1.607 | 0.320–8.137 | 0.555 | |
| Level of fusion | ||||
| L-spine vs. T-L junction | 1.328 | 0.459–3.367 | 0.571 | |
| L-spine vs. T-spine | < 0.001 | 0.000–0.000 | 0.986 | |
| T-L junction vs. T-spine | < 0.001 | 0.000–0.000 | 0.986 | |
*P < 0.05.
Univariate logistic regression analysis of postoperative serum liver function test elevation (> 80 units/liter for alanine transaminase, > 90 units/liter for aspartate transaminase) after spinal fusion
| Items | OR | 95% CI | ||
|---|---|---|---|---|
| Age | 1.002 | 0.980–1.026 | 0.860 | |
| Gender, women:men | 0.508 | 0.281–0.917 | 0.024* | |
| Duration of anesthesia, hr | 1.298 | 1.048–1.614 | 0.017* | |
| ASA | 0.753 | 0.332–1.644 | 0.485 | |
| No. of fused segments | 1.270 | 1.092–1.486 | 0.002** | |
| Charlson's comorbidity index | 1.080 | 0.873–1.320 | 0.455 | |
| Underlying diseases | ||||
| Hypertension | 0.817 | 0.437–1.520 | 0.524 | |
| Diabetes mellitus | 0.650 | 0.304–1.312 | 0.245 | |
| Gastrointestinal | 2.819 | 0.636–12.510 | 0.158 | |
| Hepatobiliary | 2.630 | 1.087–6.268 | 0.029* | |
| Endocrinology | 1.094 | 0.142–1.420 | 0.236 | |
| Rheumatology | 4.632 | 1.391–16.587 | 0.013* | |
| Cancer | 1.094 | 0.478–2.369 | 0.824 | |
| Surgical approach | ||||
| PLIF vs. DLIF | 1.066 | 0.359–2.827 | 0.902 | |
| PLIF vs. PLIF & DLIF | 0.375 | 0.057–1.420 | 0.208 | |
| DLIF vs. PLIF & DLIF | 0.352 | 0.046–1.854 | 0.248 | |
| Level of fusion | ||||
| L-spine vs. T-L junction | 0.991 | 0.409–2.232 | 0.982 | |
| L-spine vs. T-spine | 0.644 | 0.172–1.942 | 0.466 | |
| T-L junction vs. T-spine | 0.650 | 0.149–2.467 | 0.539 | |
*P < 0.05; **P < 0.01.
Univariate logistic regression analysis of postoperative serum total bilirubin level (1.58 mg/dL) after spinal fusion
| Items | OR | 95% CI | ||
|---|---|---|---|---|
| Age | 0.997 | 0.971–1.029 | 0.868 | |
| Gender, women:men | 0.767 | 0.349–1.729 | 0.512 | |
| Duration of anesthesia, hr | 1.431 | 1.097–1.875 | 0.008** | |
| ASA | 2.446 | 0.923–6.690 | 0.072 | |
| No. of fused segments | 1.359 | 1.133–1.637 | 0.001* | |
| Charlson's comorbidity index | 1.144 | 0.875–1.444 | 0.278 | |
| Underlying diseases | ||||
| Hypertension | 0.865 | 0.373–1.988 | 0.731 | |
| Diabetes mellitus | 0.322 | 0.074–0.968 | 0.073 | |
| Gastrointestinal | 1.008 | 0.053–6.003 | 0.994 | |
| Hepatobiliary | 3.426 | 1.213–8.957 | 0.014* | |
| Endocrinology | 0.244 | 0.013–1.253 | 0.178 | |
| Rheumatology | 0.650 | 0.035–3.573 | 0.686 | |
| Cancer | 1.873 | 0.683–4.660 | 0.194 | |
| Surgical approach | ||||
| PLIF vs. DLIF | 1.149 | 0.252–3.815 | 0.836 | |
| PLIF vs. PLIF & DLIF | 0.465 | 0.025–2.463 | 0.468 | |
| DLIF vs. PLIF & DLIF | 0.405 | 0.019–3.565 | 0.455 | |
| Level of fusion | ||||
| L-spine vs. T-L junction | 4.134 | 1.648–10.083 | 0.002** | |
| L-spine vs. T-spine | 1.068 | 0.157–4.324 | 0.935 | |
| T-L junction vs. T-spine | 0.258 | 0.036–1.182 | 0.113 | |
*P < 0.05; **P < 0.01.
Multiple logistic regression for risk factors with significant result from univariate logistic regression analysis for each outcomes
| Items | OR | 95% CI | ||
|---|---|---|---|---|
| Postoperative ileus | ||||
| Duration of anesthesia, hr | 1.324 | 0.963–1.828 | 0.082 | |
| No. of fused segments | 1.063 | 0.839–1.332 | 0.601 | |
| Diabetes mellitus | 0.279 | 0.063–0.859 | 0.042* | |
| Hepatobiliary diseases | 3.045 | 1.034–8.330 | 0.034* | |
| Elevated liver enzymes | ||||
| Gender, women:men | 0.368 | 0.188–0.704 | 0.003** | |
| Duration of anesthesia, hr | 1.112 | 0.843–1.465 | 0.448 | |
| No. of fused segments | 1.234 | 1.018–1.503 | 0.033* | |
| Hepatobiliary diseases | 2.704 | 1.077–6.700 | 0.031* | |
| Rheumatoid diseases | 5.021 | 1.434–18.916 | 0.012* | |
| Elevated total bilirubin levels | ||||
| Duration of anesthesia, hr | 1.103 | 0.772–1.565 | 0.581 | |
| No. of fused segments | 1.253 | 0.962–1.626 | 0.089 | |
| Level of fusion, L-spine vs. T-L junction | 2.899 | 0.989–8.240 | 0.051 | |
*P < 0.05; **P < 0.01.